GlassScriptPhysician profile
Andrew M Hanflik
NPI 1508008178
$4,267.06
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,907 · 2020: $128 · 2021: $1,018 · 2023: $67.35 · 2024: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,999.59 | 2019-2021 | |
| Arthrex, INC. | $986.12 | 2019 | |
| Micromed INC | $467.00 | 2019 | |
| Medical Device Business Services, INC. | $214.77 | 2021-2023 | Na |
| Zimmer Biomet Holdings, INC. | $146.65 | 2024 | Comprehensive Shoulder System |
| Wright Medical Technology, INC. | $121.91 | 2019 | |
| Radius Health, INC. | $71.34 | 2019 | |
| Pacira Therapeutics, INC. | $62.13 | 2019 | |
| Team_makena_llc | $32.61 | 2020 | |
| Djo, LLC | $28.55 | 2020 | |
| Kci USA, INC. | $22.74 | 2019 | |
| Ethicon US, LLC | $21.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.43 | 2019 | |
| Abbott Laboratories | $15.87 | 2020 | |
| Depuy Synthes Sales INC. | $15.54 | 2023 | Fms |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.67 | 2020 | |
| Ibsa Pharma INC. | $14.40 | 2020 | |
| Endo Pharmaceuticals INC. | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hanflik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.